The company is an enterprise listed company on the Shenzhen Stock Exchange. Jiyao Group's main business is a group enterprise centered on major medical and health industries such as the pharmaceutical industry (production of Chinese and Western proprietary medicines), pharmaceutical commerce (wholesale, agency), pharmaceutical retail, and medical care (pension services integrated with medical care). The company has always insisted on product quality as life, quality service as the purpose, core technology as the driving force, and highly integrated social responsibility with enterprise development. The Group has always taken “caring for life and healthy people” as the core development concept. Currently, the company's main business is the pharmaceutical health industry, forming major pharmaceutical health industry group enterprises such as pharmaceutical industry, pharmaceutical commerce (including drug retail), pharmaceutical research and development, medical care, and pharmaceutical industry investment. The pharmaceutical industry mainly produces Chinese and Western proprietary medicines, biopharmaceuticals, health foods, etc. The pharmaceutical industry mainly produces proprietary Chinese and Western medicines, biopharmaceuticals, health foods, etc. It covers Nakanishi proprietary medicine tablets, capsules, honey pills, honey pills, paste pills, concentrated pills, granules, mixtures, syrups, creams, raw materials, drops, eye drops, small-volume injections, ointments, etc.
No Data